The present invention relates to nucleic acids that are unique to tumor tissues, particularly central nervous system (CNS) tumors, such as gliomas, in particular glioblastoma, and are targets for the treatment or diagnosis of tumor diseases in a subject. And relates to the identification of amino acid sequences.